Semax is a synthetic ACTH(4-7)-related heptapeptide investigated in controlled models of neurotrophin-associated signaling, melanocortin-related pathways, and cellular stress response. Results are highly dependent on model, exposure, controls, and measured endpoint.

Representative product imagery. Verify the physical label and lot documentation on receipt.
Semax
Semax peptide supplied in a 10 mg research vial with clear batch records. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
What researchers study
Semax is a synthetic peptide reference material used in controlled neuro-signaling and sequence-stability research.
Neuro-signaling research investigates receptors, cellular communication, peptide stability, and analytical behavior in qualified in-vitro and biochemical models.
In-vitro neuro-signaling observations cannot be translated into cognitive, behavioral, psychiatric, or therapeutic claims. Appropriate controls and independent replication remain essential.
Stability studies characterize enzymatic and nonenzymatic cleavage, oxidation, adsorption, and temperature-dependent loss. Laboratories should report both intact peptide recovery and the appearance of identifiable degradants.
Analytical methods combine chromatography, mass spectrometry, and qualified controls to establish selectivity and sensitivity in the intended matrix. Experimental signaling findings cannot be translated into claims about cognition, stroke, mood, or treatment.
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review


